- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03531021
Increasing Heart Healthy Behaviors in Youth With Type 1 Diabetes
Increasing Heart Healthy Behaviors in Youth With Type 1 Diabetes: A Pilot Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Specific Aim: To develop and pilot test a modular intervention to improve heart healthy self-efficacy and behaviors in teens with type 1 diabetes at elevated cardiovascular disease risk.
Intervention Objective: To evaluate the feasibility and efficacy of a psychoeducational and behavioral intervention to improve heart healthy self-efficacy and behaviors in youth with type 1 diabetes (T1D) at elevated cardiovascular disease (CVD) CVD risk.
Secondary Objective: Assess participation in challenges involving healthy eating and physical activity.
Synopsis of Study Design
Study Design: Randomized, attention-matched trial with 1:1 randomization at a single center. Subjects will be randomized in two strata, by age (14-16 years and 17-19 years).
Study Population: Teens with type 1 diabetes.
Intervention: This pilot study involves a 6-month randomized controlled trial (RCT) comparing 2 study conditions, the behavioral intervention vs. an attention control. Youth will be randomized in 2 strata, by age (14-16 years and 17-19 years). Enrollment will end after 60 participants.
The intervention group will receive 2 modules (one in in person and one by video conference) and will receive follow-up phone calls/emails by study staff 3 weeks following each visit to review education and strategies for and barriers to reaching goals. Intervention sessions must include teen; parents may attend if they wish. Challenges will occur every 2 weeks. Participants will be on teams of about 3-5 teens and the teams may change over the course of the intervention due to staggered enrollment. As team members finish the study, newly randomized teammates will be assigned.
There will be a delayed intervention for the control group with study handouts after 3 months. The control group will meet with the research assistants (RAs) for demographic and survey completion and receive reminder phone calls/emails in order to match for attention.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02215
- Joslin Diabetes Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Teens ages 14-19 years old with T1D for ≥6 months
- Current patients at Joslin Diabetes Center
- Teens will have dyslipidemia (defined as LDL ≥100 mg/dl, HDL <40 mg/dl or triglycerides ≥130 mg/dl in past year), overweight or obesity (BMI percentile ≥85th at screening), prehypertensive or hypertensive blood pressure on day of screening visit, or A1c ≥8.0%
- Youth and parents must be English speaking, without significant learning disabilities, and intend to continue care at our center.
- Access to a smart phone with video conferencing capabilities
Exclusion Criteria:
- Participation in an interventional study within the past 3 months.
- Unwilling to comply with study procedures
- Prescribed BP and/or lipid-lowering medications (besides over-the-counter supplements)
- Contraindication to exercise
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Heart healthy intervention
The intervention group will receive 2 modules (one in in person and one by video conference) and will receive follow-up phone calls/emails by study staff 3 weeks following each visit to review education and strategies for and barriers to reaching goals.
Intervention sessions must include teen; parents may attend if they wish.
Participants will be placed on teams and encouraged to complete behavioral challenges to earn points towards a cash reward.
|
Intervention consists of educational modules, goal setting and brainstorming around strategies and barriers, and a series of heart healthy challenges such as walking a certain number of steps or eating healthy foods a certain number of times in a week.
|
No Intervention: Attention Control
There will be a delayed intervention for the control group with study handouts after 3 months.
The control group will meet with the RAs for demographic and survey completion and receive reminder phone calls/emails in order to match for attention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adolescent Food Habits Checklist
Time Frame: 3 months
|
healthy eating questionnaire, 23 question true/false survey, score range from 0-23, higher scores indicate healthier habits, no subscales.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adiposity
Time Frame: 3 months
|
changes in zbmi
|
3 months
|
Blood pressure
Time Frame: 3 months
|
Changes in blood pressure percentile
|
3 months
|
Changes in lipid levels
Time Frame: 3 months
|
Changes in lipid levels from before study until study end
|
3 months
|
Activity level
Time Frame: 3 months
|
Documentation of how active participants were during study
|
3 months
|
Exercise Confidence Survey
Time Frame: 3 months
|
evaluation of self-efficacy for exercise
|
3 months
|
Healthy Eating Self-Efficacy Survey
Time Frame: 3 months
|
healthy eating self-efficacy measure
|
3 months
|
Eating Habits Confidence Survey
Time Frame: 3 months
|
evaluation of how confident participants are that they can eat in a healthy way
|
3 months
|
Acceptance of medication for CVD risk survey
Time Frame: 3 months
|
brief questions to evaluate willingness to take medication if prescribed
|
3 months
|
Engagement with behavioral challenges
Time Frame: 3 months
|
Proportion of intervention participants who completed challenges
|
3 months
|
Change in weight
Time Frame: 3 months
|
change in weight in kg between enrollment and study completion
|
3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Lori Laffel, Joslin Diabetes Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017-34
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type1diabetes
-
Silesian Centre for Heart DiseasesThe Jerzy Kukuczka Academy of Physical Education in KatowiceCompletedtype1diabetesPoland
-
Vastra Gotaland RegionCompletedType1diabetesSweden
-
Rabin Medical CenterThe Leona M. and Harry B. Helmsley Charitable Trust; DreaMed DiabetesRecruiting
-
The Hospital for Sick ChildrenCanadian Institutes of Health Research (CIHR)Completed
-
University of Southern CaliforniaThe Leona M. and Harry B. Helmsley Charitable TrustCompletedType1diabetesUnited States
-
Aalborg University HospitalAalborg University; Steno Diabetes Center NordjyllandCompletedType1diabetes | Hemodialysis | Type2DiabetesDenmark
-
Radboud University Medical CenterUnknownType1diabetes | Hypoglycemia UnawarenessNetherlands
-
Vastra Gotaland RegionRecruitingType1diabetes | Psychology Functional BehaviorSweden
-
University of PennsylvaniaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...Active, not recruitingHypoglycemia | Type1diabetes | Islet Cell Transplantation | Hypoglycemia UnawarenessUnited States
-
University of British ColumbiaJuvenile Diabetes Research Foundation; Brain CanadaNot yet recruiting
Clinical Trials on Heart healthy intervention
-
Ohio UniversityOhioHealthUnknown
-
John ParissisCompletedHeart Failure | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure NYHA Class IV | Heart Failure NYHA Class IGreece
-
The Miriam HospitalCompletedCardiovascular Disease, ArrhythmiasUnited States
-
University of California, San DiegoCompletedObesity | Cardiovascular Risk FactorsUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)National Institute for Occupational Safety and Health (NIOSH/CDC)Unknown
-
Oklahoma State University Center for Health SciencesWashington State University; The Chickasaw NationUnknownBody Weight | Blood PressureUnited States
-
University of Massachusetts, LowellNational Heart, Lung, and Blood Institute (NHLBI); Tufts University; National... and other collaboratorsCompleted
-
Tel Aviv UniversityIsrael Science FoundationCompletedPrevention Harmful EffectsIsrael
-
Medical University of South CarolinaNational Heart, Lung, and Blood Institute (NHLBI)CompletedVentricular Arrhythmia | Implantable Cardioverter DefibrillatorUnited States
-
Joslin Diabetes CenterAmerican Diabetes AssociationCompleted